:2320 (15 March 2021) DOI:10.22122/arya.v17i0.2320

Survey of coronary catheterization laboratory activity in Iran during the coronavirus disease-2019 pandemic

Mohammad Kermani-Alghoraishi, Ehsan Shirvani, Alireza Khosravi, Farshad Roghani-Dehkordi, Hasan Shemirani, Hossein Farshidi, Ahmad Reza Assareh, Seyyed Ali Moezi, Nizal Sarrafzadegan

DOI: http://dx.doi.org/10.22122/arya.v17i0.2320


BACKGROUND: With the onset of the coronavirus disease-2019 (COVID-19) pandemic, hospitalization and treatment of non-covid patients decreased worldwide. The aim of this study is to evaluate the admission and treatment of patients with coronary artery diseases (CADs) by examining coronary Cath labs activities in some centers of Iran during the COVID-19 period.

METHODS: A retrospective, multi-center survey was conducted in four cites in Iran which participated in National Persian Registry Of CardioVascular diseasE (N-PROVE). Two periods of COVID-19 occurrence peak in Iran were compared with the same date in 2019. Information was collected on the number of diagnostic and therapeutic coronary catheterizations in both stable ischemic heart diseases (SIHDs) and acute coronary syndrome (ACS) settings.

RESULTS: In the first peak of COVID-19 pandemic, coronary angiographies and angioplasties decreased by 37 and 38% compared to the same period in 2019, respectively. The most common indication for coronary angiography during this period was ACS [especially ST-Segment Elevation Myocardial Infarction (STEMI)]; however, at the time of peak decrease, the SIHDs were the most. In the second peak of COVID-19 pandemic in Iran, 34% and 27% decrease in diagnostic and therapeutic coronary procedures were seen, respectively. During this period, the number of elective admissions increased, although it was still lower than that in 2019. The tendency to rescue percutaneous coronary intervention increased in most centers during the COVID-19 era, especially in the second peak.

CONCLUSION: A significant reduction in the coronary Cath lab activity has been observed during the COVID-19 pandemic that can indicate an increased risk of cardiovascular mortality and morbidity.


Coronavirus Disease-2019; Coronary Angiography; Coronary Angioplasty; ST-Segment Elevation Myocardial Infarction; Survey

Full Text:



Daoulah A, Hersi AS, Al-Faifi SM, Alasmari A, Aljohar A, Balghith M, et al. STEMI and

COVID-19 pandemic in Saudi Arabia. Curr Probl Cardiol 2021; 46(3): 100656.

Rodriguez-Leor O, Cid-Alvarez B, Ojeda S, Martin-Moreiras J, Ramon Rumoroso J, Lopez-Palop R, et al. Impact of the COVID-19 pandemic on interventional cardiology activity in Spain. REC Interv Cardiol 2020; 2(2): 82-9.

Adlan AM, Lim VG, Dhillon G, Kurdi H, Doolub G, Elamin N, et al. Impact of COVID-19 on primary percutaneous coronary intervention centres in the UK: A survey. Br J Cardiol 2020; 27: 51-4.

Elliott JM, Crozier IG. Decreases in cardiac catheter laboratory workload during the COVID-19 level 4 lockdown in New Zealand. Intern Med J 2020; 50(8): 1000-3.

Roffi M, Capodanno D, Windecker S, Baumbach A, Dudek D. Impact of the COVID-19 pandemic on interventional cardiology practice: results of the EAPCI survey. EuroIntervention 2020; 16(3): 247-50.

Mayol J, Artucio C, Batista I, Puentes A, Villegas J, Quizpe R, et al. An international survey in Latin America on the practice of interventional cardiology during the COVID-19 pandemic, with a particular focus on myocardial infarction. Neth Heart J 2020; 28(7-8): 424-30.

Khosravi A, Mansouri A, Shahsanayi F, Paydari N, Heshmat-Ghahdarijani K, Mansourian M, et al. Rationale and design of the Persian cardiovascular disease registry (PCVDR): Scale-up of Persian registry of CardioVascular DiseasE (PROVE). Curr Probl Cardiol 2021; 46(3): 100577.

Givi M, Sarrafzadegan N, Garakyaraghi M, Yadegarfar G, Sadeghi M, Khosravi A, et al. Persian Registry of cardioVascular diseasE (PROVE): Design and methodology. ARYA Atheroscler 2017; 13(5): 236-44.

Zeng J, Huang J, Pan L. How to balance acute myocardial infarction and COVID-19: The protocols from Sichuan Provincial People's

Hospital. Intensive Care Med 2020; 46(6): 1111-3.

Mahmud E, Dauerman HL, Welt FGP, Messenger JC, Rao SV, Grines C, et al. Management of acute myocardial infarction during the COVID-19 pandemic: A position statement from the society for cardiovascular angiography and interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP). J Am Coll Cardiol 2020; 76(11): 1375-84.

American Heart Association's Mission. Temporary emergency guidance to STEMI systems of care during the COVID-19 pandemic: AHA's mission: Lifeline. Circulation 2020; 142(3): 199-202.

De Rosa S., Spaccarotella C, Basso C, Calabro MP, Curcio A, Filardi PP, et al. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J 2020; 41(22): 2083-8.


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 4.0

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.